Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02922465 · ClinicalTrials.gov registry record · Phase 1
Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult Volunteers
A Phase 1 study, sponsored by Kowa Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT02922465 is a Phase 1 study that has completed, run by Kowa Research Institute. The registered enrollment target is 20 participants.
The verdict
NCT02922465, a Phase 1 study, has completed, sponsored by Kowa Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the effects of clopidogrel on the PK of K-877 in healthy adult subjects.
Interventions
- DRUG Clopidogrel
- DRUG K-877
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-09 |
| Est. Completion | 2016-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02922465
The ClinicalTrials.gov registry entry for NCT02922465 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kowa Research Institute, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Clopidogrel is the first listed.
NCT02922465 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02922465 about?
NCT02922465 is a clinical study titled "Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult Volunteers". The primary objective of this study is to assess the effects of clopidogrel on the PK of K-877 in healthy adult subjects.
What is the current status of trial NCT02922465?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2016-09. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02922465?
The interventions under investigation include: Clopidogrel (DRUG), K-877 (DRUG).
Who is sponsoring clinical trial NCT02922465?
This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.